Related references
Note: Only part of the references are listed.Genetic and clinical characteristics associated with efficacy and retention rates of colchicine in Japanese patients with familial Mediterranean fever: A single-center observational study
Kazusato Hara et al.
MODERN RHEUMATOLOGY (2021)
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
Serdal Ugurlu et al.
RHEUMATOLOGY (2021)
Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients A Single-Center Real-Life Study
Hakan Babaoglu et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2020)
Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry
Erdal Sag et al.
RHEUMATOLOGY (2020)
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
Mark Kacar et al.
JOURNAL OF INFLAMMATION RESEARCH (2020)
Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
Afig Berdeli et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2019)
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
F. De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments
Seza Ozen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
EULAR recommendations for the management of familial Mediterranean fever
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Dysregulated mature IL-1β production in familial Mediterranean fever
Kiyoshi Migita et al.
RHEUMATOLOGY (2015)
Familial Mediterranean Fever Genotype-Phenotype Correlations in Japanese Patients
Kiyoshi Migita et al.
MEDICINE (2014)
Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever A Randomized Trial
Philip J. Hashkes et al.
ANNALS OF INTERNAL MEDICINE (2012)
Familial Mediterranean Fever in Japan
Kiyoshi Migita et al.
MEDICINE (2012)
Colchicine nonresponsiveness in familial Mediterranean fever: Clinical, genetic, pharmacokinetic, and socioeconomic characterization
M Lidar et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus
S Papin et al.
HUMAN MOLECULAR GENETICS (2000)